Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New atlas maps how skin ages using 3D collagen scans

NCT ID NCT07409675

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to create a visual guide to skin aging by taking detailed 3D images of collagen in the skin of 250 healthy women aged 20 to 75. Using a special camera called LC-OCT, researchers measured collagen density and structure without any needles or surgery. No treatments or products were tested—the goal was simply to better understand how skin ages naturally.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Nov 2024

Finished

Feb 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy female volunteers

Ages

20 to 75 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject having signed an Informed Consent Form (ICF) before any trial related activity is carried out; * Healthy female subject aged 20 to 75 years inclusive at the time of signing the ICF; * Subject with a phototype I to III on Fitzpatrick's scale; * Subject who is willing to follow the study procedures and to complete the study course; * Subject registered with Social Security in agreement with French law on study research. Exclusion Criteria: * Male subject; * Female subject who is pregnant or who is breast feeding; * Subject with current participation in any other interventional clinical study, based on interview of the subject; * Subject with facial dermatitis, rosacea, acne, eczema, psoriasis, skin rashes, open lesions, vitiligo or viral conditions such as herpes labialis; * Subject who has collagen vascular disease, a significant systemic disease, immunological problems or inflammatory skin conditions on the face; * Subject who has had a face lift; * Subject has had a non-ablative and/or ablative laser procedure on the face in the past 3 months; * Subject with a history of botulinum toxin or mesotherapy injections on the face within the last 6 months, or absorbable fillers injections (such as hyaluronic acid or autologous fat…) in the last 12 months or injectable implants (semi-permanent fillers) within the last 24 months; * Subject having done a moderate to deep peeling or non-invasive rejuvenation techniques such as radiofrequency, ultrasound and lasers in the last 6 months; * Subject having applied any cosmetic product (care cream, lotion, makeup) except usual cleansing products or any drug to her face on the day of the visit; * Subject who has been deprived of their freedom by administrative or legal decision, or who is under care of a guardian or legal guardianship, or subject hospitalized in a medical or social establishment for any reason.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CPCAD, Hôpital l'Archet 2

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.